The Role Of Leptin And Adiponectin In Disorders Of Fatter Tissue In Metabolic Syndrome
Keywords:
Abstract
In this article, opinions were expressed on the improvement of early-stage diagnostic factors and the optimal pathways of therapeutic treatment, having determined the characteristics of heterogeneous neurohumorals of metabolic syndrome, the clinical manifesto of the disease. The analysis of the study shows that the issues of pathogenesis, clinical features of improving the effectiveness of medicamentous therapy, and treatment-rehabilitation aspects have not been studied perfectly so far. In patients with metabolic syndrome, hypotensive, anti-adipose agents, as well as treatment of statins and improvement of the prophylactic order of prevention of diseases, the issues of which were not studied at the end were discussed.
Similar Articles
-
The Meaning Of Questionnaires In Assessing The Quality Of Life Of Patients With Type 2 Diabetes On Software Hemodialysis
The American Journal of Medical Sciences and Pharmaceutical Research: No. 06 (2021) / Kholikov Alisher Yusupovich, Urmanova Yulduz Makhkamovna, -
Communication Of Quality Of Life Indicators, Functional Methods Of Research And Neuromarker BNDF In Patients With Diabetes Mellitus 2 With Diabetic Foot Syndrome
The American Journal of Medical Sciences and Pharmaceutical Research: No. 05 (2021) / Alimkhanov Olimkhon Omilkhonovich, Kamalov Telman Tulyaganovich, -
Competence Approach Is An Integrating Factor Of Training Future Doctors
The American Journal of Medical Sciences and Pharmaceutical Research: No. 03 (2021) / Ashurova Oyistaxon Yuldashevna, -
Research On The Choice Of “Ambronat” Syrup Technology
The American Journal of Medical Sciences and Pharmaceutical Research: No. 02 (2021) / Yunusova Kholida Mannanovna , Abdijalilova Zilola Hikmatullaevna , -
Assessment Of Clinical And Psychological Status And Quality Of Life Of Patients In Different Forms Of Irritable Bowel Syndrome
The American Journal of Medical Sciences and Pharmaceutical Research: No. 02 (2021) / Abdullayev R.B., Makhmudova L.I., -
Morphological Peculiarities Of The Spleen In Normality And With The Influence Of A Gene-Modified Product In Experiment
The American Journal of Medical Sciences and Pharmaceutical Research: No. 04 (2021) / Dilnoza Akhrorovna Khasanova, -
Ecological And Hygienic Aspects Of Optimization Of Water Supply Of The Population
The American Journal of Medical Sciences and Pharmaceutical Research: No. 04 (2021) / Feruzakhon Tulkinjonovna Abduvalieva, Feruza Lyutpillaevna Azizova `, -
The Intensity Of Dental Caries In Workers Is Harmful Industry
The American Journal of Medical Sciences and Pharmaceutical Research: No. 05 (2021) / Nazarova Nodira Sharipovna, Rakhimberdiev Rustam Abdunosirovich , Bakirov Asadullo Abdikodirovich, Sultonov Odiljon Raimovich, -
A SET OF DIAGNOSTIC, TACTICAL AND THERAPEUTIC MEASURES TO IMPROVE THE TREATMENT OF ACUTE AND CHRONIC PARAPROCTITIS
The American Journal of Medical Sciences and Pharmaceutical Research: No. 03 (2022) / RustamovMurodullaIsomiddinovich, RustamovInoyatullaMuradullaevich, -
MODERN ASPECTS OF SURGICAL TREATMENT OF ACUTE AND CHRONIC PARAPROCTITIS
The American Journal of Medical Sciences and Pharmaceutical Research: No. 03 (2022) / RustamovMurodullaIsоmiddinovich, SaydullaevZayniddinYaxshiboevich, RustamovInoyatullaMuradullaevich,
References
Uzbekova N.R. Modern concepts of insulin-like growth factors in normal conditions and their role in diabetes mellitus . Volume: 02 Issue: 02 | March-April 2021 ISSN: 2660-4159 pp.236-239.
www.cajmns.centralasianstudies.org/index.php
Uzbekova N.R. Neuro humoral mechanisms of the pathogenesis of the metabolic syndrome and ways of their therapeutic correction. Abstract of doctoral (DsC) dissertation on medical sciences. 2017 year.
Bagdade J.D., Buchanan W.F., Pollare T., LithellH.Abnormal lipoprotein phospholidip composition in patients with essential hypertension // Atherosclerosis 2009.-117: pp.209-215 .
Bruns M.W., Hall J.E. Hyperinsulinemia and hypertonia. NMCD 2003; 3: pp.155-157.
Despres J.P. The insulin resistance-dyslipidemic syndrome of visceral obesity: effect on patients risk. Obesity Res. 2008; 6: pp.89-179.
Esler M., Rumanier., Wiesner G. et al. Sympathetic nervous system and insylin resistance. From obesite to diabetes // Am. J. Hypertens. 2008- 14: pp.304-309.
Camus J. Goutte, diabete, hyperlipemie: un trisyndrome metaboliqul. Rev Rhumat. 2006; 33:pp.10-14.
Cusi K., Defronzo R.A. Metgormin: a revien of its metabolic effects. Diabetes Reviews. 2004; 6: pp.89-131.
Reaven G. M. Insulin resistance/compensatory hyperinsulinimia, essential hypertension, and cardiovascular disease. J. ClinEndocrindMetab. 2007;
Heseeler J.R., Morel D.W., Leves J., Chisolm G.M., Lipoprotens oxidation and lipoprotein-indused cytotoxicity. // Atherosclerosis. 2006; 3: pp215-222
Froze E. Age related changes in postprandial plasma glucose, insulin and FFA concentrations in non-diabetic individuals / E. Froze, M. Chiou, Y. Chen, G.M. Raeven // J Am Geriatr Soc.-2011.- Vol. 35,- pp. 224-228.
Furchgott R.F. The obligatoryrole of endotnelial cells in the relazation of arterial smooth muscle by acetylcholine / R.F. Furchgott, J.V. Zawadszki // Nature.- 2009.- Vol. 288.- pp. 373-376.
Anize Delfino von Frankenberg. Relationships between adiponectin levels, the metabolic syndrome, and type 2 diabetes: a literature review.
http://www.scielo.br/scielo.php?script=sci_serial&pid=2359-3997&lng=en&nrm
issn 2359-4292. 2017 year
